Top Markets
Coin of the day
Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL
Rankning i aktier #18093
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Aktiekurs
$10.22
Senast synkroniserad: 2026-07-31
Marknadsvärde
$212.97M
Förändring (1 dag)
4.58%
Förändring (1 år)
78.08%
Land
CA
Handel Satellos Bioscience Inc. (MSCL)

Kategori

Aktiekurshistorik för Satellos Bioscience Inc. (MSCL)
Högsta slutkurs: $9.26 den 2026-07-01

Lägsta slutkurs: $152.54 den 2008-01-01
Aktiekurshistorik för Satellos Bioscience Inc. från 2008 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 29.26%
2025 -20.28%
2024 84.25%
2023 91.27%
2022 -80.10%
2021 2.79%
2020 -11.41%
2019 10.94%
2018 37.66%
2017 -27.41%
2016 41.02%
2015 -8.55%
2014 -90.26%
2013 -52.35%
2012 195.82%
2011 -36.68%
2010 -30.40%
2009 333.63%
2008 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.05 -8.95%
AU
$757.71 6.76%
CH